Repligen
RGEN
#2045
Rank
HK$72.29 B
Marketcap
HK$1,284
Share price
-0.47%
Change (1 day)
16.01%
Change (1 year)
Categories

Repligen (RGEN) - Cash on Hand

Cash on Hand as of September 2025 : HK$5.82 Billion

According to Repligen 's latest financial reports the company has HK$5.82 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$5.87 B0.2%
2023-12-31HK$5.86 B20.4%
2022-12-31HK$4.87 B3.51%
2021-12-31HK$4.70 B-15.33%
2020-12-31HK$5.56 B35.12%
2019-12-31HK$4.11 B171.13%
2018-12-31HK$1.51 B11.8%
2017-12-31HK$1.35 B23.48%
2016-12-31HK$1.09 B97.63%
2015-12-31HK$0.55 B22.7%
2014-12-31HK$0.45 B-5.12%
2013-12-31HK$0.47 B53.91%
2012-12-31HK$0.31 B
2011-03-31HK$0.38 B-6.46%
2010-03-31HK$0.41 B8.98%
2009-03-31HK$0.37 B-2.26%
2008-03-31HK$0.38 B119.12%
2007-03-31HK$0.17 B20.21%
2006-03-31HK$0.14 B9.62%
2005-03-31HK$0.13 B23.48%
2004-03-31HK$0.10 B-10.28%
2003-03-31HK$0.12 B-25.5%
2002-03-31HK$0.16 B-12.93%
2001-03-31HK$0.18 B-29.54%
2000-03-31HK$0.26 B935.59%
1999-03-31HK$25.58 M-29.76%
1998-03-31HK$36.42 M34.3%
1997-03-31HK$27.11 M-49.18%
1996-03-31HK$53.36 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novavax
NVAX
HK$5.93 B 1.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$11.50 B 97.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$8.67 B 48.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$105.15 B 1,704.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$27.60 B 373.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$128.45 B 2,103.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$116.64 B 1,901.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$1.12 B-80.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.23 B-96.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$1.61 B-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA